What makes diaper rash products harder to source than baby lotion (regulatory path, labeling, actives)?

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

• Diaper rash SKUs are harder to source than baby lotion mainly because the regulatory path can shift from “cosmetic” to “OTC drug” in the US when you use skin-protectant actives (common examples: zinc oxide, petrolatum, dimethicone) and make treatment/prevention claims.
• That typically triggers Drug Facts labeling requirements, tighter claim/ingredient alignment, and more robust quality documentation expectations than a basic moisturizing lotion.
• From a sourcing standpoint, high-solid formulas (e.g., zinc oxide creams/pastes) are also more sensitive to stability and packaging compatibility (settling, separation, tube crimping, clogging), so you usually need more iteration during sampling and longer validation time.
• How we support: custom formula development + lab sampling, label/claims alignment support, and arranging third-party testing with report tracking (e.g., microbial, stability/compatibility, and active-related checks as needed).
• For planning, bulk production is typically 10-20 working days after final sample confirmation; packaging procurement often takes 10-30 working days (e.g., tubes ~15 days, cartons 15-20 days).
• Typical MOQ guidance starts around 3,000-10,000 units per SKU depending on formula and pack; we can confirm after you choose format and claims.
• We can provide barcodes, core documents, and packaging/VI coordination; we cannot guarantee FDA outcomes but can support the documentation/testing package.